Edgen Stock·Sep 13 2025, 03:25戻る
戻る
Tempus AI's PurIST® Algorithm Validated for Pancreatic Cancer Therapy Selection
Edgen Stock·Sep 13 2025, 03:25
[1] Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer (https://finance.yahoo.com/news/tempus-announc ...)[2] TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape | Nasdaq (https://vertexaisearch.cloud.google.com/groun ...)[3] TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape - Zacks (https://www.zacks.com/stock/news/2480000/tem- ...)